Weintraub M S, Eisenberg S, Breslow J L
Laboratory of Biochemical Genetics and Metabolism, Rockefeller University, New York, New York 10021.
J Clin Invest. 1987 Dec;80(6):1571-7. doi: 10.1172/JCI113243.
Apolipoprotein E (apo E) plays an important role in receptor mediated clearance of lipoprotein particles from plasma. Common genetic variation in apo E exists with three alleles coding for proteins called E2, E3, and E4. In in vitro receptor binding assays, E2 binds poorly, whereas E3 and E4 function normally. Recently, the apo E phenotype has been shown to have an effect on low density lipoprotein (LDL) cholesterol levels with levels in subjects with E2 lower and E4 higher than E3. We have examined the effect of the apo E polymorphism on dietary fat clearance using the vitamin A-fat loading test, which specifically labels intestinally derived lipoproteins with retinyl palmitate (RP). 27 normal subjects were studied, 10 with E3/3, 9 with E3/2, 7 with E4/3, and 1 with E4/4. After a vitamin A-containing fatty meal, postprandial RP concentrations were measured in chylomicron (Sf greater than 1,000) and nonchylomicron (Sf less than 1,000) fractions for 14 h. Compared with E3/3 subjects, E3/2 subjects had a significantly higher nonchylomicron RP concentration (P less than 0.05) (peak heights and areas below the curves) indicating slower clearance and the E4/3, E4/4 group had a significantly lower nonchylomicron RP concentration (P less than 0.05) indicating faster clearance. The clearance in the latter group was twice that of E3/2 subjects (P less than 0.01). Thus, heterozygosity for the defective form of apo E, E2, delays, and the surprising presence of a functionally normal allele, E4, increases clearance. This apo E effect on exogenous fat clearance may explain the recently described effect of the apo E phenotypes on LDL cholesterol levels.
载脂蛋白E(apo E)在受体介导的血浆脂蛋白颗粒清除过程中发挥着重要作用。apo E存在常见的基因变异,有三个等位基因,分别编码名为E2、E3和E4的蛋白质。在体外受体结合试验中,E2结合能力差,而E3和E4功能正常。最近研究表明,apo E表型对低密度脂蛋白(LDL)胆固醇水平有影响,E2携带者的LDL胆固醇水平低于E3携带者,E4携带者的LDL胆固醇水平高于E3携带者。我们使用维生素A - 脂肪负荷试验研究了apo E基因多态性对膳食脂肪清除的影响,该试验用棕榈酸视黄酯(RP)特异性标记肠道来源的脂蛋白。研究了27名正常受试者,其中10名E3/3型,9名E3/2型,7名E4/3型,1名E4/4型。食用含维生素A的脂肪餐后,在14小时内测定乳糜微粒(Sf大于1000)和非乳糜微粒(Sf小于1000)组分中的餐后RP浓度。与E3/3型受试者相比,E3/2型受试者的非乳糜微粒RP浓度显著更高(P小于0.05)(峰值高度和曲线下面积),表明清除较慢;而E4/3、E4/4组的非乳糜微粒RP浓度显著更低(P小于0.05),表明清除较快。后一组的清除速度是E3/2型受试者的两倍(P小于0.01)。因此,apo E缺陷形式E2的杂合性会延迟清除,而功能正常的等位基因E4的存在则会加快清除。apo E对外源性脂肪清除的这种作用可能解释了最近所描述的apo E表型对LDL胆固醇水平影响的原因。